BENJAMIN LI to Aromatase Inhibitors
This is a "connection" page, showing publications BENJAMIN LI has written about Aromatase Inhibitors.
Connection Strength
0.058
-
Real-world palbociclib dose modifications and clinical outcomes in patients with HR+/HER2- metastatic breast cancer: A Flatiron Health database analysis. Breast. 2025 Jun; 81:104448.
Score: 0.058